- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glucose Tolerance Impaired in Korea, Democratic People's Republic of
Total 745 results
-
Ahvaz Jundishapur University of Medical SciencesUnknownType 2 DiabetesIran, Islamic Republic of
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompletedOverweight | Type 2 Diabetes | ObeseIran, Islamic Republic of
-
Nahid ZarifsanaieyCompletedDiabetes Mellitus, Type 1 | Self-ManagementIran, Islamic Republic of
-
AstraZenecaCompletedHypertensionKorea, Republic of
-
Semnan University of Medical SciencesCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusIran, Islamic Republic of
-
Baqiyatallah Medical Sciences UniversityCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedCoronary Artery Disease | Metabolic SyndromeIran, Islamic Republic of
-
University of Banja LukaActive, not recruitingMetabolic SyndromeBosnia and Herzegovina
-
Shahid Beheshti University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Daiichi Sankyo, Inc.Daiichi Sankyo Korea Co., Ltd.CompletedDyslipidemia Associated With Type II Diabetes MellitusKorea, Republic of
-
Tehran University of Medical SciencesCompletedDiabetes Mellitus | Chronic Kidney Disease | Radiocontrast-Induced NephropathyIran, Islamic Republic of
-
Shiraz University of Medical SciencesCompletedCoronary Artery Disease | Insulin ResistanceIran, Islamic Republic of
-
Novo Nordisk A/SEnrolling by invitation
-
University of Banja LukaEnrolling by invitationDiabetes Mellitus, Type 2Bosnia and Herzegovina
-
Birjand University of Medical SciencesCompletedHyperglycemia | Metabolic Syndrome | Hypercholesterolemia | HypertriglyceridemiaIran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
International Diabetes Institute, AustraliaGlaxoSmithKlineCompletedType 2 Diabetes MellitusChina, Indonesia, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
Shiraz University of Medical SciencesCompletedDiabetes Mellitus, Type 2 | Fatty LiverIran, Islamic Republic of
-
Shiraz University of Medical SciencesCompletedDiabetes Mellitus, Type 2 | Sleep DisturbanceIran, Islamic Republic of
-
National Nutrition and Food Technology InstituteCompletedType 2 Diabetes Nonalcoholic Fatty LiverIran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | Essential HypertensionIran, Islamic Republic of
-
Alborz Medical UniversityUniversiti Putra MalaysiaCompletedVitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, IranHypertension | Diabetes Mellitus | Vitamin D Deficiency | Lipid Metabolism Disorders | Obesity, AbdominalIran, Islamic Republic of
-
Gilead SciencesCompletedLong QT SyndromeUnited States, Romania, Moldova, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Shiraz University of Medical SciencesCompletedDiabetic Nephropathy | Chronic Kidney Disease | Diabetes Type 2Iran, Islamic Republic of
-
University of Sistan and BaluchestanNiloofar Zareie Mohammad ZadehCompletedMetabolic Syndrome | Non-alcoholic Fatty Liver Disease | Women's Health | Middle Aged | Hybrid TrainingIran, Islamic Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
National Nutrition and Food Technology InstituteUnknownMetabolic SyndromeIran, Islamic Republic of
-
National Nutrition and Food Technology InstituteUnknownMetabolic SyndromeIran, Islamic Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Korea, Republic of, Hungary, Canada, Australia
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Israel, Korea, Republic of, Turkey, Italy, Belgium, United Kingdom, Greece, Ireland, Sweden, Denmark, Finland, France, Czech Republic
-
Novo Nordisk A/SCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
NYU Langone HealthRecruitingParkinson Disease | Multiple System Atrophy | Neurogenic Orthostatic Hypotension | REM Sleep Behavior Disorder | Pure Autonomic Failure | Dementia With Lewy Bodies | Patients With Synucleinopathies | Shy-Drager DiseaseKorea, Republic of, United States, Argentina, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Spain, Sweden, India, Mexico, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chile, Puerto Rico
-
TakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 1France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Korea, Republic of, China, Turkey
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, France, Guatemala, Italy, Korea, Republic of, Mexico, Poland, Russian Federation
-
SanofiCompletedDiabetes Mellitus, Type 2United States, France, Canada, Brazil, Russian Federation, Germany, Italy, Turkey, India, Mexico, Egypt, United Kingdom, Korea, Republic of, Chile, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India